The in vivo dissolution of tricalcium silicate bone cement.

J Biomed Mater Res A

School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA.

Published: December 2021

This study aimed to investigate the in vivo dissolution of tricalcium silicate (Ca SiO , C S) bone cement in the rabbit femoral defect. Results indicated that C S paste directly integrated with the bone tissue without the protection of the bone-like apatite. Calcium silicate hydrate gel (C-S-H gel) and Ca(OH) were the main components of C S paste. The dissolution model of C S paste was a mass loss rather than a decrease in volume. The initial dissolution of C S paste (0 ~ 6 weeks) was greatly attributed to the release of Ca(OH) , and the later dissolution (>6 weeks) was attributed to the decalcification of C-S-H gel. Although the mass of C S paste could decrease by more than 19 wt % after 6 weeks of implantation, the created pores (<1 μm) were not large enough for the bone tissue to migrate into C S paste. The loss of Ca ions also resulted in the transformation of SiO tetrahedrons from Q and Q to Q , Q , and Q in C-S-H gel. Because only isolated SiO tetrahedrons (Q ) and Ca ions could be absorbed by the bone tissue, C S paste gradually transformed into a silica-rich gel. The fundamental reason for no decrease in volume of C S paste was that the SiO tetrahedron network still maintained the frame structure of C S paste during the implantation.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbm.a.37247DOI Listing

Publication Analysis

Top Keywords

vivo dissolution
8
dissolution tricalcium
8
tricalcium silicate
8
bone cement
8
c-s-h gel
8
paste
5
silicate bone
4
cement study
4
study aimed
4
aimed investigate
4

Similar Publications

Controlled-release microparticles offer a promising avenue for enhancing patient compliance and minimizing dosage frequency. In this study, we aimed to design controlled-release microparticles of Glipizide utilizing Eudragit S100 and Methocel K 100 M polymers as controlling agents. The microparticles were fabricated through a simple solvent evaporation method, employing various drug-to-polymer ratios to formulate different controlled-release batches labeled as F1 to F5.

View Article and Find Full Text PDF

Morphological Features Influence the Drug Loading and Delivery Efficacy of Photoactivatable Gold Nanocarriers for Antitumor Photo/Chemotherapy.

ACS Appl Mater Interfaces

January 2025

Institute of Optical Functional Materials for Biomedical Imaging, School of Chemistry and Pharmaceutical Engineering, Shandong First Medical University & Shandong Academy of Medical Science, Taian, Shandong 271016, PR China.

Photoactivatable gold nanocarriers are transforming antitumor therapies by leveraging their distinctive physicochemical properties, enabling targeted drug delivery and enhanced therapeutic efficacy in cancer treatment. This study systematically investigates how surface topography and morphology of gold nanocarriers influence drug loading capacity, light-to-heat conversion efficiency, and overall therapeutic performance in photo/chemotherapy. We synthesized four distinct morphologies of gold nanoparticles: porous gold nanocups (PAuNCs), porous gold nanospheres (PAuNSs), solid gold nanocups (SAuNCs), and solid gold nanospheres (SAuNSs).

View Article and Find Full Text PDF

Background/objectives: A sustained-release formulation of fenofibrate while enhancing drug dissolution with minimal food effect is critical for maximizing the therapeutic benefits of fenofibrate. Therefore, this study aimed to develop an effective solid dispersion formulation of fenofibrate for simultaneous enhancement in the extent and duration of drug exposure.

Methods: Fenofibrate-loaded solid dispersions (FNSDs) were prepared using poloxamer 407 and Eudragit RSPO at varied ratios via solvent evaporation.

View Article and Find Full Text PDF

Background: Lipid vesicles, especially those utilizing biocompatible materials like chitosan (CHIT), hold significant promise for enhancing the stability and release characteristics of drugs such as indomethacin (IND), effectively overcoming the drawbacks associated with conventional drug formulations.

Objectives: This study seeks to develop and characterize novel lipid vesicles composed of phosphatidylcholine and CHIT that encapsulate indomethacin (IND-ves), as well as to evaluate their in vitro hemocompatibility.

Methods: The systems encapsulating IND were prepared using a molecular droplet self-assembly technique, involving the dissolution of lipids, cholesterol, and indomethacin in ethanol, followed by sonication and the gradual incorporation of a CHIT solution to form stable vesicular structures.

View Article and Find Full Text PDF

This study investigates the impact of supercritical antisolvent (SAS) process parameters on the particle formation of telmisartan, a poorly water-soluble drug. A fractional factorial design was employed to examine the influence of the SAS process parameters, including solvent ratio, drug solution concentration, temperature, pressure, injection rate of drug solution, and CO₂ flow rate, on particle formation. Solid-state characterizations of the SAS process particles using XRD and FT-IR confirmed their amorphous nature.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!